SCHEMBL1154960

SCHEMBL1154960

C1CCC2C3CCC2C(C1)C3

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
HSD11B1 P28845 1/20 0.37
EPAS1 Q99814 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6689602 1.00 ALDH1A1 (0.44) ALDH1A1HSD11B1EPAS1
SCHEMBL2011115 0.93 ALDH1A1 (0.35) ALDH1A1HSD11B1EPAS1
SCHEMBL212308 0.93 ALDH1A1 (0.50) ALDH1A1HSD11B1EPAS1
SCHEMBL2253089 0.93 ALDH1A1 (0.50) ALDH1A1HSD11B1EPAS1
SCHEMBL829179 0.93 ALDH1A1 (0.40) ALDH1A1HSD11B1EPAS1
SCHEMBL13464122 0.90 ALDH1A1 (0.47) ALDH1A1HSD11B1EPAS1
SCHEMBL6688863 0.90 ALDH1A1 (0.47) ALDH1A1HSD11B1EPAS1
SCHEMBL6277727 0.90 ALDH1A1 (0.47) ALDH1A1HSD11B1EPAS1
SCHEMBL30875827 0.90 HSD11B1 (0.43) ALDH1A1HSD11B1EPAS1
SCHEMBL20511602 0.86 HSD11B1 (0.34) ALDH1A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110034628-A1 BRANCHED POLYOLS CONTAINING ON AVERAGE TWO OR MORE HYDROXYL GROUPS PER MOLECULE,THEIR PREPARATION AND USE BASF COATINGS AG (DE) 2011-02-10 US claimed
EP-0082967-A2 Traction fluid Optimol-Ölwerke GmbH (DE) 1983-07-06 EP claimed
EP-2493991-B1 ANTIREFLECTIVE COMPOSITION FOR PHOTORESISTS MERCK PATENT GMBH (DE) 2016-03-02 EP disclosed
EP-1672050-B1 LUBRICATING OIL COMPOSITION IDEMITSU KOSAN CO (JP) 2015-12-09 EP disclosed
EP-2009304-B1 TORQUE LIMITER JTEKT CORP (JP) 2014-10-01 EP disclosed
EP-2003353-B1 TORQUE LIMITER JTEKT CORP (JP) 2014-06-04 EP disclosed
US-8551686-B2 Antireflective composition for photoresists AZ ELECTRONIC MATERIALS USA CORP. (US) 2013-10-08 US disclosed
EP-2052293-B1 ANTIREFLECTIVE COMPOSITION FOR PHOTORESISTS AZ ELECTRONIC MATERIALS USA (US) 2013-03-13 EP disclosed
EP-2493991-A1 ANTIFEFLECTIVE COMPOSITION FOR PHOTORESISTS AZ Electronic Materials USA Corp. (US) 2012-09-05 EP disclosed
US-8230986-B2 Torque limiter JTEKT CORPORATION (JP) 2012-07-31 US disclosed
US-8220609-B2 Torque limiter JTEKT CORPORATION (JP) 2012-07-17 US disclosed
US-20080076059-A1 Antireflective coating compositions MERCK PATENT GMBH (DE) 2008-03-27 US disclosed
WO-2008017954-A2 ANTIREFLECTIVE COMPOSITION FOR PHOTORESISTS AZ ELECTRONIC MATERIALS USA CORP. (DE) 2008-02-14 WO disclosed
US-20080038659-A1 Antireflective composition for photoresists MERCK PATENT GMBH (DE) 2008-02-14 US disclosed
US-20080021055-A1 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists AVENTIS PHARMA S.A. 2008-01-24 US disclosed
US-20070042915-A1 Lube base oil and lubricating oil composition IDEMITSU KOSAN CO., LTD. (JP) 2007-02-22 US disclosed
EP-1672050-A1 LUBE BASE OIL AND LUBRICATING OIL COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2006-06-21 EP disclosed
US-6207663-B1 AS INHIBITORS OF BONE RESORPTION, TUMOR GROWTH, TUMOR METASTASIS, OR INFLAMMATION, OR FOR THE TREATMENT OR PROPHYLAXIS OF CARDIOVASCULAR DISORDERS, NEPHROPATHIES OR RETINOPATHIES HOECHST ATKIENGESELLSCHAFT (DE) 2001-03-27 US disclosed
WO-1995014008-A1 SUBSTITUTED 5-RING HETEROCYCLES, THEIR PREPARATION AND THEIR USE HOECHST AKTIENGESELLSCHAFT (DE) 1995-05-26 WO disclosed
EP-0082967-A2 Traction fluid Optimol-Ölwerke GmbH (DE) 1983-07-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021055-A1 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists ADGRF1, ADGRE5, CALCR ALDH1A1 3827/4885HSD11B1 2308/4885EPAS1 2529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.